Benmu Biotechnology, as a subsidiary of Kuo Kuang Biotech, focuses on the research and development, production, and promotion of animal vaccines and animal health products. Adhering to our parent company's deep technological accumulation and innovative gene, we are committed to safeguarding global animal health with cutting-edge biotechnology and promoting the sustainable development of the modern farming and breeding industry.

With "technology as the cornerstone, health as the mission" as its core philosophy, Benmu continuously innovates its biotechnology platforms to develop highly efficient vaccines targeting a variety of animal diseases, covering livestock, pets, and other special animal fields. At the same time, we actively expand our animal nutrition and health product lines to provide global farmers and breeders with comprehensive health solutions, improving animal welfare and reducing disease risks and economic losses during the farming and breeding process.

Guided by an international perspective and local needs, Benmu possesses a professional team that combines laboratory research and development with industrial practice. The company not only follows top international standards in its research, development, and production processes, but also actively participates in domestic and international cooperative projects to jointly push the boundaries of biotechnology applications in the field of animal health.

Looking to the future, Benmu Biotechnology will continue to dedicate itself to creating innovative and sustainable animal health solutions, injecting new vitality into the global farming and breeding industry and pet market. We firmly believe that healthy animals will create a more prosperous ecological environment and a better future.
(The content above was translated by AI.)